Tenax Therapeutics
(TENX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 1,540 | 2,555 | 2,918 | 2,862 | 2,719 |
| Operating Income | -1,540 | -2,555 | -2,918 | -2,862 | -2,719 |
| Interest Expense | 7 | 0 | 0 | 2 | 3 |
| Other Income | 140 | 8 | -1 | 2 | 0 |
| Pre-tax Income | -1,407 | -2,547 | -2,919 | -2,861 | -2,721 |
| Net Income Continuous | -1,407 | -2,547 | -2,919 | -2,861 | -2,721 |
| Net Income | $-1,407 | $-2,549 | $-2,917 | $-2,861 | $-2,722 |
| EPS Basic Total Ops | -12.10 | -68.71 | -177.60 | -181.60 | -172.80 |
| EPS Basic Continuous Ops | -12.13 | -75.85 | -170.46 | -181.65 | -172.76 |
| EPS Diluted Total Ops | -12.10 | -68.71 | -177.60 | -181.60 | -172.80 |
| EPS Diluted Continuous Ops | -12.13 | -75.85 | -170.46 | -181.65 | -172.76 |
| EBITDA(a) | $-1,539 | $-2,525 | $-2,889 | $-2,834 | $-2,691 |